Helminth products protect against autoimmunity via innate type 2 cytokines IL-5 and IL-33, which promote eosinophilia

Journal of Immunology

Volumn 196, Issue 2, 2016, Pages 703-714

  Finlay, Conor M ^a   Stefanska, Anna M ^a   Walsh, Kevin P ^a   Kelly, Patrick J ^a   Boon, Louis ^b   Lavelle, Ed C ^a   Walsh, Patrick T ^c   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EPIRUS Biopharmaceuticals Netherlands BV   (Netherlands)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; IL33 PROTEIN, MOUSE; PARASITE ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EOSINOPHIL; EOSINOPHILIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FASCIOLA HEPATICA; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ANTIGENS, HELMINTH; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EOSINOPHILIA; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERLEUKIN-33; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TH2 CELLS;

EID: 84954107583     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501820     Document Type: Article

References (58)

1. Finlay, C. M., K. P. Walsh, and K. H. G. Mills. 2014. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol. Rev. 259: 206-230.
2. Correale, J., and M. Farez. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61: 97-108.
3. Correale, J., and M. F. Farez. 2011. The impact of parasite infections on the course of multiple sclerosis. J. Neuroimmunol. 233: 6-11.
4. Elliott, D. E., A. Metwali, J. Leung, T. Setiawan, A. M. Blum, M. N. Ince, L. E. Bazzone, M. J. Stadecker, J. F. Urban, Jr., and J. V. Weinstock. 2008. Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J. Immunol. 181: 2414-2419.
5. Hübner, M. P., Y. Shi, M. N. Torrero, E. Mueller, D. Larson, K. Soloviova, F. Gondorf, A. Hoerauf, K. E. Killoran, J. T. Stocker, et al. 2012. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-b. J. Immunol. 188: 559-568.
6. Wilson, M. S., M. D. Taylor, M. T. O'Gorman, A. Balic, T. A. Barr, K. Filbey, S. M. Anderton, and R. M. Maizels. 2010. Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40: 1682-1696.
7. Walsh, K. P., M. T. Brady, C. M. Finlay, L. Boon, and K. H. Mills. 2009. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J. Immunol. 183: 1577-1586.
8. Croese, J., J. O'neil, J. Masson, S. Cooke, W. Melrose, D. Pritchard, and R. Speare. 2006. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 55: 136-137.
9. Summers, R. W., D. E. Elliott, J. F. Urban, Jr., R. Thompson, and J. V. Weinstock. 2005. Trichuris suis therapy in Crohn's disease. Gut 54: 87-90.
10. Harnett, W., I. B. McInnes, and M. M. Harnett. 2004. ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potential. Immunol. Lett. 94: 27-33.
11. Sewell, D., Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 15: 59-69.
12. Elliott, D. E., J. Li, A. Blum, A. Metwali, K. Qadir, J. F. Urban, Jr., and J. V. Weinstock. 2003. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G385-G391.
13. Cooke, A., P. Tonks, F. M. Jones, H. O'Shea, P. Hutchings, A. J. Fulford, and D. W. Dunne. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21: 169-176.
14. Cayrol, C., and J.-P. Girard. 2014. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31: 31-37.
15. Hung, L.-Y., I. P. Lewkowich, L. A. Dawson, J. Downey, Y. Yang, D. E. Smith, and D. R. Herbert. 2013. IL-33 drives biphasic IL-13 production for non-canonical Type 2 immunity against hookworms. Proc. Natl. Acad. Sci. USA 110: 282-287.
16. Yasuda, K., T. Muto, T. Kawagoe, M. Matsumoto, Y. Sasaki, K. Matsushita, Y. Taki, S. Futatsugi-Yumikura, H. Tsutsui, K. J. Ishii, et al. 2012. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl. Acad. Sci. USA 109: 3451-3456.
17. Oboki, K., T. Ohno, N. Kajiwara, K. Arae, H. Morita, A. Ishii, A. Nambu, T. Abe, H. Kiyonari, K. Matsumoto, et al. 2010. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107: 18581-18586.
18. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
19. Zimmermann, N., M. L. McBride, Y. Yamada, S. A. Hudson, C. Jones, K. D. Cromie, P. R. Crocker, M. E. Rothenberg, and B. S. Bochner. 2008. Siglec-F antibody administration to mice selectively reduces blood and tissue eosino-phils. Allergy 63: 1156-1163.
20. Carranza, F., C. R. Falcón, N. Nuñez, C. Knubel, S. G. Correa, I. Bianco, M. Maccioni, R. Fretes, M. F. Triquell, C. C. Motrán, and L. Cervi. 2012. Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells. PLoS One 7: e40356.
21. Helft, J., J. Böttcher, P. Chakravarty, S. Zelenay, J. Huotari, B. U. Schraml, D. Goubau, and C. Reis e Sousa. 2015. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells. Immunity 42: 1197-1211.
22. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune en-cephalomyelitis as demonstrated by studies of IL-10-and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
23. Dai, H., B. Ciric, G. X. Zhang, and A. Rostami. 2012. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. J. Neuroimmunol. 245: 1-7.
24. Urban, J. F., Jr., K. B. Madden, A. Svetić, A. Cheever, P. P. Trotta, W. C. Gause, I. M. Katona, and F. D. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127: 205-220.
25. Brown, W. C., W. C. Davis, D. A. Dobbelaere, and A. C. Rice-Ficht. 1994. CD4+ T-cell clones obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm antigen express both unrestricted and Th2 cytokine profiles. Infect. Immun. 62: 818-827.
26. Jager, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomy-elitis with different pathological phenotypes. J. Immunol. 183:7169-7177.
27. Smith, P., N. E. Mangan, C. M. Walsh, R. E. Fallon, A. N. McKenzie, N. van Rooijen, and P. G. Fallon. 2007. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol. 178: 4557-4566.
28. Huang, L., N. G. Gebreselassie, L. F. Gagliardo, M. C. Ruyechan, N. A. Lee, J. J. Lee, and J. A. Appleton. 2014. Eosinophil-derived IL-10 supports chronic nematode infection. J. Immunol. 193: 4178-4187.
29. Flynn, R. J., G. Mulcahy, and H. M. Elsheikha. 2010. Coordinating innate and adaptive immunity in Fasciola hepatica infection: implications for control. Vet. Parasitol. 169: 235-240.
30. Clutterbuck, E., J. G. Shields, J. Gordon, S. H. Smith, A. Boyd, R. E. Callard, H. D. Campbell, I. G. Young, and C. J. Sanderson. 1987. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur. J. Immunol. 17: 1743-1750.
31. Hardman, C. S., V. Panova, and A. N. J. McKenzie. 2013. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur. J. Immunol. 43: 488-498.
32. Byers, D. E., J. Alexander-Brett, A. C. Patel, E. Agapov, G. Dang-Vu, X. Jin, K. Wu, Y. You, Y. Alevy, J.-P. Girard, et al. 2013. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J. Clin. Invest. 123: 3967-3982.
33. Strachan, D. P. 2000. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 55(Suppl 1): S2-S10.
34. Zaccone, P., O. Burton, N. Miller, F. M. Jones, D. W. Dunne, and A. Cooke. 2009. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 39: 1098-1107.
35. Hübner, M. P., J. T. Stocker, and E. Mitre. 2009. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 127: 512-522.
36. Moreau, E., and A. Chauvin. 2010. Immunity against helminths: interactions with the host and the intercurrent infections. J. Biomed. Biotechnol. 2010: 428593.
37. Mulcahy, G., S. O'Neill, J. Fanning, E. McCarthy, and M. Sekiya. 2005. Tissue migration by parasitic helminths-an immunoevasive strategy? Trends Parasitol. 21: 273-277.
38. Saunders, K. A., T. Raine, A. Cooke, and C. E. Lawrence. 2007. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect. Immun. 75: 397-407.
39. La Flamme, A. C., K. Ruddenklau, and B. T. Bäckström. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71: 4996-5004.
40. Zheng, X., X. Hu, G. Zhou, Z. Lu, W. Qiu, J. Bao, and Y. Dai. 2008. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J. Neuroimmunol. 194: 107-114.
41. Brady, M. T., S. M. O'Neill, J. P. Dalton, and K. H. Mills. 1999. Fasciola he-patica suppresses a protective Th1 response against Bordetella pertussis. Infect. Immun. 67: 5372-5378.
42. Tran, G. T., S. J. Hodgkinson, N. M. Carter, N. D. Verma, K. M. Plain, R. Boyd, C. M. Robinson, M. Nomura, M. Killingsworth, and B. M. Hall. 2012. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity. Blood 119: 4441-4450.
43. Yoshida, T., K. Ikuta, H. Sugaya, K. Maki, M. Takagi, H. Kanazawa, S. Sunaga, T. Kinashi, K. Yoshimura, J. Mayazaki, et al 1996. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Ra-deficient mice. Immunity. 4: 483-494.
44. Culley, F. J., A. Brown, D. M. Conroy, I. Sabroe, D. I. Pritchard, and T. J. Williams. 2000. Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J. Immunol. 165: 6447-6453.
45. McSorley, H. J., N. F. Blair, K. A. Smith, A. N. J. McKenzie, and R. M. Maizels. 2014. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol. 7: 1068-1078.
46. Akuthota, P., H. Wang, L. Spencer, and P. Weller. 2008. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin. Exp. Allergy. 38: 1254-1263.
47. Shi, H. Z., A. Humbles, C. Gerard, Z. Jin, and P. F. Weller. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105: 945-953.
48. Padigel, U. M., J. J. Lee, T. J. Nolan, G. A. Schad, and D. Abraham. 2006. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect. Immun. 74: 3232-3238.
49. Akuthota, P., H. Wang, and P. F. Weller. 2010. Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr. Opin. Allergy Clin. Immunol. 10: 14-19.
50. Del Pozo, V., B. De Andrés, E. Martin, B. Cárdaba, J. C. Fernández, S. Gallardo, P. Tramón, F. Leyva-Cobian, P. Palomino, and C. Lahoz. 1992. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur. J. Immunol. 22: 1919-1925.
51. Li, M., Y. Li, X. Liu, X. Gao, and Y. Wang. 2012. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. J. Neuroimmunol. 247: 25-31.
52. Xu, D., H. R. Jiang, P. Kewin, Y. Li, R. Mu, A. R. Fraser, N. Pitman, M. Kurowska-Stolarska, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2008. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105: 10913-10918.
53. Palmer, G., D. Talabot-Ayer, C. Lamacchia, D. Toy, C. A. Seemayer, S. Viatte, A. Finckh, D. E. Smith, and C. Gabay. 2009. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 60: 738-749.
54. Jiang, H.-R., M. Milovanović, D. Allan, W. Niedbala, A.-G. Besnard, S. Y. Fukada, J. C. Alves-Filho, D. Togbe, C. S. Goodyear, C. Linington, et al. 2012. IL-33 attenuates EAE by suppressing IL-17 and IFN-g production and inducing alternatively activated macrophages. Eur. J. Immunol. 42: 1804-1814.
55. Barbour, M., D. Allan, H. Xu, C. Pei, M. Chen, W. Niedbala, S. Y. Fukada, A.-G. Besnard, J. C. Alves-Filho, X. Tong, et al. 2014. IL-33 attenuates the development of experimental autoimmune uveitis. Eur. J. Immunol. 44: 3320-3329.
56. Lefrançais, E., S. Roga, V. Gautier, A. Gonzalez-de-Peredo, B. Monsarrat, J.-P. Girard, and C. Cayrol. 2012. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 109: 1673-1678.
57. Lüthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic cas-pases. Immunity 31: 84-98.
58. Luzina, I. G., E. M. Pickering, P. Kopach, P. H. Kang, V. Lockatell, N. W. Todd, J. C. Papadimitriou, A. N. J. McKenzie, and S. P. Atamas. 2012. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J. Immunol. 189: 403-410.